These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1926674)

  • 41. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.
    Chartier-Kastler EJ; Ruud Bosch JL; Perrigot M; Chancellor MB; Richard F; Denys P
    J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Parasympathicolytic treatment of abnormal neurogenic bladder function: a urodynamic study (author's transl)].
    Wolters A; Sökeland J; Weil W; Kopf H
    Dtsch Med Wochenschr; 1980 Sep; 105(39):1344-7. PubMed ID: 7460781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Trospium chloride in combined treatment of females with genital prolapse and overactive urinary bladder].
    Shkol'nikov Me; Mazo EB; Krivoborodov GG; Dobrokhotova IuE; Kaĭfadzhan MM; Fandeeva LV; Nurullin RF; Zhdanova MS
    Urologiia; 2008; (5):16-9. PubMed ID: 19069489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
    Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
    J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
    Horst M; Weber DM; Bodmer C; Gobet R
    Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
    Araki I; Matsui M; Ozawa K; Takeda M; Kuno S
    J Urol; 2003 Apr; 169(4):1384-7. PubMed ID: 12629367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions.
    Bagi P; Biering-Sørensen F
    Scand J Urol Nephrol; 2004; 38(6):495-8. PubMed ID: 15841785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder.
    Neel KF; Soliman S; Salem M; Seida M; Al-Hazmi H; Khatab A
    J Urol; 2007 Dec; 178(6):2593-7; discussion 2597-8. PubMed ID: 17945300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
    Schulte-Baukloh H; Mürtz G; Henne T; Michael T; Miller K; Knispel HH
    BJU Int; 2006 Feb; 97(2):355-8. PubMed ID: 16430646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Spasmex treatment of patients with hyperactive urinary bladder].
    Pushkar' DIu; Shchaveleva OB
    Urologiia; 2003; (4):46-9. PubMed ID: 12942728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study.
    Schulte-Baukloh H; Mürtz G; Heine G; Austin P; Miller K; Michael T; Strugala G; Knispel HH
    J Pediatr Urol; 2012 Aug; 8(4):386-92. PubMed ID: 21907623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
    Hermieu JF;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
    Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
    Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the anticonvulsant medications pregabalin and lamotrigine on urodynamic parameters in an animal model of neurogenic detrusor overactivity.
    Loutochin O; Al Afraa T; Campeau L; Mahfouz W; Elzayat E; Corcos J
    Neurourol Urodyn; 2012 Sep; 31(7):1197-202. PubMed ID: 22473872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
    Giannantoni A; Di Stasi SM; Nardicchi V; Zucchi A; Macchioni L; Bini V; Goracci G; Porena M
    J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.